Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics. Filing since 13 Mar 2024.
CIK 0001716213
Company
Date
Role
Action
Shares
Amount
Of holding
APRE
Aprea Therapeutics, Inc.
30 Jan 2026
SrVP/CFO/Prin Fin & Acct Ofcr
Bought
5,700
$5.07K
20.6%
APRE
Aprea Therapeutics, Inc.
10 Dec 2025
SrVP/CFO/Prin Fin & Acct Ofcr
Bought
5,000
$5.83K
22.0%
APRE
Aprea Therapeutics, Inc.
11 Oct 2024
SrVP/CFO/Prin Fin & Acct Ofcr
Bought
50
$123.19
0.3%
APRE
Aprea Therapeutics, Inc.
10 Oct 2024
SrVP/CFO/Prin Fin & Acct Ofcr
Bought
450
$1.17K
2.4%
APRE
Aprea Therapeutics, Inc.
13 Mar 2024
SrVP/CFO/Prin Fin & Acct Ofcr
Bought
1,010
$7.36K
7.0%
5 decisions on file.
